InvestorsHub Logo
Followers 4
Posts 87
Boards Moderated 0
Alias Born 02/12/2007

Re: None

Monday, 05/03/2010 9:36:23 AM

Monday, May 03, 2010 9:36:23 AM

Post# of 39
Penwest Pharma beats by $0.03, beats on revsFont size: A | A | A8:35 AM ET 5/3/10 | Briefing.com
Reports Q1 (Mar) earnings of $0.12 per share, $0.03 better than the single estimate of $0.09; revenues rose 66.0% year/year to $8.8 mln vs the $7.9 mln estimate. Co notes that this was their third consecutive profitable quarter, and that they began to receive the full royalty rate for Opana ER during Q1.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.